Raziel Therapeutics
Rehovot
About Raziel Therapeutics
Raziel Therapeutics is a pharmaceutical company that develops an injectable treatment. They develop RZL-012, which is designed to be injected into subcutaneous fat and results in a considerable and long-lasting reduction in fat volume. Raziel is currently conducting a number of clinical trials for various fat issue indications as well as aesthetics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $22.2M
- Last round: Series Unknown (Oct 2025)
- Website: raziel-therapy.com
- Phone: [email protected]
Industries & Categories
Health Care, Manufacturing, Medical, Wellness
Canonical: https://fsome.com/organization/raziel-therapeutics-4926 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.